ReviewBiomedicines2025
The Concept of the Optimal Bioscaffold: Parameters, Problems, and Their Resolution Through Additive Manufacturing.
Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Bioresorbable Vascular Stents: How Neutrophil Extracellular Traps Influence Biocompatibility, Degradation Kinetics, and Device Performance.Bioengineering (Basel, Switzerland) · 2026Review
- The cutting-edge advancements in biomaterials under the guidance of intelligence and bionics.Regenerative biomaterials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In regenerative medicine, an engineered tissue is a composition of a sample of cells cultured on a spatially controlled medical device, called a biological scaffold (or just a bioscaffold). These devices are made of tissue-equivalent materials and represent the biological, mechanical, and spatial conditions in a specific type of human or animal tissue, becoming a possible way to replace damaged structures and develop artificial tissues or organs. Scaffolds with narrowly controlled characteristics-biological, mechanical and spatial properties-are vital for experiments mimicking in vivo conditions and in tissue regeneration scenarios. The aim of this narrative review is to identify and discuss the most important properties of these artificial constructs and the ways to achieve them via 3D printing-based technologies. Properties that can direct the development and differentiation of the cultured cells in a specific direction and ensure their biocompatibility and bioresorption, mechanical properties, spatial architecture, and porosity are discussed. The most common considerations in terms of the role of material selection, additives, and signal molecules and the appropriate spatially controlled manufacturing technologies for their assembly are covered, as are the radiological, biomechanical, and histological methods for their analysis. Finally, this paper highlights the challenges to the achievement of optimal scaffolds through additive manufacturing and gives suggestions for further research and development in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.